Roche's 2020 Losses to Biosimilars Were "Worst It Can Get"

Retrieved on: 2021-02-09 14:26:15

Tags for this article:

Life Sciences

Health care

Roche Pharmaceuticals

Click the tags to see associated articles and topics

Roche's 2020 Losses to Biosimilars Were "Worst It Can Get". View article details on HISWAI: https://www.centerforbiosimilars.com/view/roche-2020-losses-to-biosimilars-worst-it-can-get-

Excerpt

Biosimilar competition took a big chunk of revenue from Roche's aging blockbusters in 2020, and the company is banking on its newer medicines to ...

Article found on: www.centerforbiosimilars.com

View Original Article